[HTML][HTML] Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty …
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
Transient elastography (FibroScan (®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver …
I Mikolasevic, L Orlic, N Franjic… - World journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver …
I Mikolašević, L Orlić, N Franjić, G Hauser… - World J …, 2016 - dabar.srce.hr
Abstract (english) Non-alcoholic fatty liver disease (NAFLD) is the most common cause of
chronic liver disease worldwide. Currently, the routinely used modalities are unable to …
chronic liver disease worldwide. Currently, the routinely used modalities are unable to …
[HTML][HTML] Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty …
I Mikolasevic, L Orlic, N Franjic, G Hauser… - World Journal of …, 2016 - wjgnet.com
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
Transient elastography (FibroScan (®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver …
I Mikolasevic, L Orlic, N Franjic, G Hauser… - World Journal of …, 2016 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
Transient elastography (FibroScan (®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver …
I Mikolašević, L Orlić, N Franjić, G Hauser… - World journal of …, 2016 - croris.hr
Sažetak Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver
disease worldwide. Currently, the routinely used modalities are unable to adequately …
disease worldwide. Currently, the routinely used modalities are unable to adequately …
[PDF][PDF] Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty …
I Mikolasevic, L Orlic, N Franjic, G Hauser… - World J …, 2016 - core.ac.uk
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver …
I Mikolašević, L Orlić, N Franjić… - World J …, 2016 - repository.medri.uniri.hr
Abstract (english) Non-alcoholic fatty liver disease (NAFLD) is the most common cause of
chronic liver disease worldwide. Currently, the routinely used modalities are unable to …
chronic liver disease worldwide. Currently, the routinely used modalities are unable to …
[引用][C] Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty …
I Mikolasevic, L Orlic, N Franjic, G Hauser… - World Journal of …, 2016 - cir.nii.ac.jp
Transient elastography (FibroScan<sup>®</sup>) with controlled attenuation parameter in
the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease …
the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease …
Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver …
I Mikolašević, L Orlić, N Franjić… - World J …, 2016 - unirepository.svkri.uniri.hr
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. Currently, the routinely used modalities are unable to adequately determine the …
worldwide. Currently, the routinely used modalities are unable to adequately determine the …